XML 13 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities:    
Loss for the period $ (48,441) $ (39,527)
Non-cash adjustments to reconcile loss for the period to net cash flows:    
Depreciation and amortization 62 52
Non-cash rent expense (16) 3
Fair value change - derivative earnout and warrants (5,942) (17,754)
Loss on disposal of property, plant and equipment 12  
Foreign exchange (gains)/losses 1,613 (4,293)
Amortization of premium/discount on available-for-sale debt securities 10 (513)
Share-based compensation 18,002 15,213
Changes in working capital:    
Changes in prepayments and other receivables 15,219 16,031
Changes in accounts payable (793) 2,251
Changes in accrued expenses and other current liabilities (10,330) (4,953)
Changes in deferred revenue   (2,978)
Net cash used in operating activities (30,604) (36,468)
Investing activities:    
Purchase of property, plant and equipment, including internal use software (38) (16)
Maturities of marketable securities 51,000 12,500
Purchases of marketable securities (62,471) (9,629)
Net cash (used in)/provided by investing activities (11,509) 2,855
Financing activities:    
Transaction costs on December 2024 issue of Ordinary Shares and Pre-Funded Warrants   (1,586)
Proceeds from exercise of warrants 651 183
Proceeds from exercise of options 10,414 7,922
Net cash provided by financing activities 11,065 6,519
Net change in cash, cash equivalents and restricted cash (31,048) (27,094)
Foreign exchange differences (1,332) 3,771
Cash, cash equivalents and restricted cash at the beginning of the period 491,323 771,743
Cash, cash equivalents and restricted cash at the end of the period 458,943 748,420
Noncash financing and investing activities    
Issuance of earnout shares   40,807
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets    
Cash and cash equivalents 457,607 748,420
Restricted cash 1,336  
Cash, cash equivalents and restricted cash $ 458,943 $ 748,420